Quick Answer
Akso Health Group reported Diluted EPS of $0.16 per share (loss) for fiscal year 2025.
Akso Health Group Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.16 | -128.6% |
| 2024 | -$0.07 | -250.0% |
| 2023 | -$0.02 | +92.9% |
| 2022 | -$0.28 | +60.6% |
| 2021 | -$0.71 | +51.4% |
| 2020 | -$1.46 | -1560.0% |
| 2019 | $0.10 | -92.7% |
| 2018 | $1.37 | +585.0% |
| 2017 | $0.20 | +150.0% |
| 2016 | $0.08 | — |
- Akso Health Group showed a decrease of -128.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2016–2025 period, Akso Health Group’s diluted eps has declined by 300.0% (from $0.08 per share to $0.16 per share (loss)).
- The most recent figure is from Akso Health Group’s fiscal year 2025 report (Form 20-F), filed with the SEC on August 14, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: